Comparative Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Comparative Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine — Stella

Home/Nicotine Dependence/

View on ClinicalTrials.gov

Recruiting

Back to Nicotine Dependence trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Zuckerberg San Francisco General Hospital (ZSFG), San Francisco, California

Key details

Phase

Early testing

Sponsor

University of California, San Francisco

Collaborators

National Institute on Drug Abuse (NIDA)

Enrollment target

~18 participants

Started

December 2024

Primary completion

September 2026

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

21 Years – 65 Years

Last updated December 2025